2023年渴睡症 (發作性嗜睡症) 的新希望?

World's first drug research program to help narcolepsy sufferers

A trial in Sydney is underway on a drug that mimics the missing neurotransmitters that cause the debilitating sleep condition narcolepsy, opening the door to effective treatments.

The institute's professor, a sleep expert with more than 30 years of experience, said he has launched the world's first research program on orexin agonists, a class of drugs that stimulate the neurotransmitter orexin receptors. , which is absent or lacking in narcolepsy patients.

Narcolepsy (types 1 and 2) is a chronic condition that affects up to 6,000 Australians and is characterized by excessive daytime sleepiness, sleep paralysis, dreamlike hallucinations, automatic behaviors, and approximately 60 to 70% people develop narcolepsy. Sufferers have partial or complete loss of muscle control in response to emotions such as laughter.

Cataplexy, hallucinations, and sleep paralysis are all manifestations of REM sleep intruding into the waking state.

The mechanisms of the disease are poorly understood, but people with narcolepsy and cataplexy have low or undetectable levels of orexin in the fluid surrounding their brains.

Only a small group of neurons in the outer hypothalamus, the part of the brain that controls behaviors such as sleep, hunger, body temperature and arousal, produce orexin. In turn, these neurons project widely to brain centers that promote alertness. Orexin sends signals to other parts of the brain to prevent cataplexy, hallucinations and sleep paralysis.

In classic narcolepsy, orexin neurons degenerate or are lost entirely, meaning people with narcolepsy don't produce much or any orexin. In some other forms of severe sleepiness, there are problems with orexin neuron signaling.

The professor said: "Several companies are developing different orexin-based drugs, and preliminary studies have shown that these drugs have a remarkable ability to keep people with narcolepsy awake and productive. We are excited to be able to provide a new treatment for this dangerous and potentially dangerous drug . Affordable and effective treatments are available for the devastating disease. Narcolepsy causes people to fall asleep without their knowledge and can cause people to lose all muscle tone after experiencing strong emotions such as laughter, anger, etc. Additionally, There are many more people with other narcolepsy disorders related to problems with orexin transmission in the brain."

A recent phase 2 clinical trial of an oral orexin agonist (TAK-994) for the treatment of narcolepsy randomly assigned 73 patients to different doses of the drug or matching placebo for eight weeks. The professors, who wrote about the trial in a recent editorial for the New England Journal of Medicine (NEJM), argued that although the trial was stopped in October 2021 due to elevated liver enzymes, "reduction in large Efficacy Signal for Most Liver Enzymes” The narcolepsy aspect was particularly strong in the trial. "

They concluded, "Although development of TAK-994 has been discontinued, there is good reason to continue using orexin agonists to treat narcolepsy type 1 and perhaps other conditions, such as shift work sleep disorder or jet lag, Experiments are being carried out for this."

Recently participated in a global trial of the long-acting drug sodium oxybate, which is currently being launched in overseas countries as a first-line drug for the treatment of narcolepsy, which can improve sudden loss of muscle control (cataplexy) and help patients sleep at night.

Short-acting sodium oxybate is classified as a controlled substance in Australia and is only approved for use in special circumstances. It's also not covered by the Pharmaceutical Benefits Scheme, so it costs patients $15,000 to $22,000 a year, putting it out of reach for many.

The most urgent need is for patients with narcolepsy to have access to the best available medications.

The professor said despite Australia having a first-class health care system, the management of narcolepsy was significantly inadequate, leaving a group of people unable to work and with restricted lifestyles in many cases.

Review

All comments are moderated before being published

HealthyPIG Magazine

View all
Transform Your Home with the Philips Smart 1000i Air Purifier: Allergy Relief Meets Smart Living

Transform Your Home with the Philips Smart 1000i Air Purifier: Allergy Relief Meets Smart Living

In today’s fast-paced world, where indoor air quality often goes unnoticed, the Philips Air Purifier Smart 1000i Series offers a breath of fresh ai...
皮質醇管理:如何控制皮質醇?我們能夠自行管理或調節劑量嗎?

皮質醇管理:如何控制皮質醇?我們能夠自行管理或調節劑量嗎?

皮質醇是一種在壓力反應中發揮重要作用的激素,適量的皮質醇可以幫助我們應對壓力和維持健康。然而,過量或長期的高皮質醇水平可能會對身體帶來負面影響。以下我們將探討如何控制和管理皮質醇,包括自然方法、藥物干預、以及測量皮質醇的方式。 1. 自然方法調節皮質醇 壓力管理技術:研究顯示,冥想、深呼吸...
皮質醇是什麼?它如何影響我們的身體與日常生活?

皮質醇是什麼?它如何影響我們的身體與日常生活?

皮質醇(Cortisol)是一種由腎上腺分泌的激素,通常被稱為「壓力荷爾蒙」。它的主要功能是幫助身體應對壓力情境,並且在多種生理過程中扮演重要角色。皮質醇的釋放受腦部下丘腦-垂體-腎上腺軸(HPA軸)控制,這是一個調節人體反應於壓力的系統。 皮質醇對身體的影響 當我們處於壓力下時,皮質...
為什麼我們在緊張時總是忍不住吃零食?科學解密壓力性飲食行為

為什麼我們在緊張時總是忍不住吃零食?科學解密壓力性飲食行為

當人們感到緊張或壓力時,經常會無意識地吃零食,這種行為主要涉及大腦的多巴胺系統、情緒反應以及身體的生理需求。以下是背後的幾個主要原因: 壓力荷爾蒙的影響:壓力會觸發皮質醇的釋放,這種壓力激素會引發人們對高糖和高脂肪食物的渴望。這些食物能帶來短暫的愉悅感,因為它們能刺激大腦分泌多巴胺,讓人感...
光學治療濕疹 - 全面總結

光學治療濕疹 - 全面總結

簡介 光療使用光波來治療某些皮膚問題。皮膚會暴露於紫外線 (UV) 光下一段設定的時間。光療利用人造的紫外線光源,紫外線也來自陽光。當與一種叫做甲氧補骨脂素的藥物一起使用時,這個程序稱為 PUVA 光療。 紫外線光能夠抑制皮膚中的免疫系統細胞,對於因免疫系統過度反應引起的皮膚問題有幫助。可以使...
什麼是「操縱者」?

什麼是「操縱者」?

操縱者,也可以說成「擅用手段的人」,「心機重的人」。操縱者利用欺騙、影響或者其他形式的心理操控來控制或影響他人,以達到自己的目標。他們的行為通常包含使用隱蔽、間接或偷偷摸摸的手法來獲得他們想要的東西,往往是以犧牲他人為代價。以下是一些常見的特徵和手段: 欺騙: 他們可能會說謊或扭曲事實來誤...
什麼是肌肉抽搐?你需要去看醫生嗎?

什麼是肌肉抽搐?你需要去看醫生嗎?

肌肉抽搐,也稱為肌束顫動,是指身體各部分出現不自主的肌肉收縮。以下是肌肉抽搐的原因、症狀及管理方法的詳細介紹: 肌肉抽搐的原因 壓力和焦慮 高水平的壓力和焦慮會導致肌肉緊張和抽搐。身體對壓力的反應會觸發神經系統,導致肌肉不自主地收縮。 疲勞 過度使用或劇烈運動後的肌肉疲勞會導致肌...
蘋果與牙齒健康:保護牙齒的小技巧

Apples and Dental Health: Tips to Protect Your Teeth

Apples are widely loved for their rich nutritional content and refreshing taste. However, apples' acidic and sugary content may also have an impact...
蘋果籽的毒性:它們真的有毒嗎?

Apple Seed Toxicity: Are They Really Poisonous?

Apple seeds contain cyanogenic glycosides, compounds that break down in the body to produce cyanide, which has raised concerns about the toxicity o...